These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12745867)

  • 1. Prolonged systemic delivery of tirofiban in a thrombus-laden saphenous vein graft.
    Gruberg L; Amikam S
    Int J Cardiovasc Intervent; 2003; 5(2):92-4. PubMed ID: 12745867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of saphenous venous graft thrombus by tirofiban infusion.
    Sentürk T; Aydin Kaderli A; Aydin O; Yeşilbursa D; Akin Serdar O
    Heart Lung; 2010; 39(3):237-9. PubMed ID: 20457345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators.
    Zhao XQ; Théroux P; Snapinn SM; Sax FL
    Circulation; 1999 Oct; 100(15):1609-15. PubMed ID: 10517731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes.
    Yip HK; Wu CJ; Chang HW; Hsieh YK; Fang CY; Chen SM; Chen MC
    Chest; 2003 Sep; 124(3):962-8. PubMed ID: 12970024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tirofiban administration and percutaneous coronary intervention with stenting of saphenous vein graft thrombosis.
    D'andrea C; Esposito G; Piscione F; Chiariello M
    J Cardiovasc Med (Hagerstown); 2009 Nov; 10(11):875-8. PubMed ID: 19644385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of tirofiban and clopidogrel pretreatment on outcome of old saphenous vein graft stenting in patients with acute coronary syndromes.
    Ozkan M; Sag C; Yokusoglu M; Uzun M; Baysan O; Erinc K; Isik E
    Tohoku J Exp Med; 2005 May; 206(1):7-13. PubMed ID: 15802870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts.
    Barsness GW; Buller C; Ohman EM; Schechter E; Pucillo A; Taylor MA; Miller MJ; Reiner JS; Churchill D; Chandler AB; Gonzalez M; Smith J; Tommaso C; Berdan LG; Wildermann NM; Hasdai D; Holmes DR
    Am Heart J; 2000 May; 139(5):824-9. PubMed ID: 10783216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombus predicts ischemic complications during percutaneous coronary intervention in saphenous vein grafts: results from TARGET (do Tirofiban and ReoPro give similar efficacy trial?).
    Kalyanasundaram A; Blankenship JC; Berger P; Herrmann H; McClure R; Moliterno D
    Catheter Cardiovasc Interv; 2007 Apr; 69(5):623-9. PubMed ID: 17192960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective.
    Dyke CM
    Am Heart J; 1999 Oct; 138(4 Pt 2):307-16. PubMed ID: 10502236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraprocedural thrombus formation during coil placement in ruptured intracranial aneurysms: treatment with systemic application of the glycoprotein IIb/IIIa antagonist tirofiban.
    Bruening R; Mueller-Schunk S; Morhard D; Seelos KC; Brueckmann H; Schmid-Elsaesser R; Straube A; Mayer TE
    AJNR Am J Neuroradiol; 2006; 27(6):1326-31. PubMed ID: 16775291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of glycoprotein IIb/IIIa inhibitors in the treatment of degenerated aortocoronary saphenous vein grafts].
    Brück M; Ludwig J; Flachskampf FA; Daniel WG
    Z Kardiol; 2002 Jan; 91(1):16-23. PubMed ID: 11963202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction.
    Martínez-Ríos MA; Rosas M; González H; Peña-Duque MA; Martínez-Sánchez C; Gaspar J; García H; Gaxiola E; Delgado L; Carrillo J; Leyva JL; Lupi E;
    Am J Cardiol; 2004 Feb; 93(3):280-7. PubMed ID: 14759375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tirofiban (Aggrastat). A non-peptide glycoprotein IIb/IIIa receptor inhibitor].
    Rasmussen S; Husted SE
    Ugeskr Laeger; 2001 Jan; 163(4):461-5. PubMed ID: 11218789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pre-hospital glycoprotein IIb-IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI.
    Hermanides RS; van Werkum JW; Ottervanger JP; Breet NJ; Gosselink AT; van Houwelingen KG; Dambrink JH; Hamm C; ten Berg JM; van 't Hof AW;
    Catheter Cardiovasc Interv; 2012 May; 79(6):956-64. PubMed ID: 22162050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience with the low-molecular-weight heparin, enoxaparin, in combination with the platelet glycoprotein IIb/IIIa blocker, tirofiban, in patients with non-ST segment elevation acute coronary syndromes.
    Cohen M
    J Invasive Cardiol; 2000 Dec; 12 Suppl E():E5-9;discussion E25-8. PubMed ID: 11156722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of thrombotic saphenous vein bypass grafts using local urokinase infusion therapy with the Dispatch catheter.
    Glazier JJ; Kiernan FJ; Bauer HH; Fram DB; Primiano CA; Mitchel JF; Dougherty JE; McKay RG
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):261-7. PubMed ID: 9213024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. EPIC Investigators. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications.
    Mak KH; Challapalli R; Eisenberg MJ; Anderson KM; Califf RM; Topol EJ
    Am J Cardiol; 1997 Oct; 80(8):985-8. PubMed ID: 9352964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tirofiban in treatment of stent thrombosis.
    Yalçin R; Taçoy G; Timurkaynak T; Cengel A
    Anadolu Kardiyol Derg; 2006 Jun; 6(2):180-1. PubMed ID: 16766287
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: the 'OPTIMIZE-IT' pilot randomized study.
    Talarico GP; Brancati M; Burzotta F; Porto I; Trani C; De Vita M; Todaro D; Giammarinaro M; Leone AM; Niccoli G; Andreotti F; Mazzari MA; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):245-51. PubMed ID: 19262211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta brachytherapy of an old degenerated saphenous vein graft with occlusive in-stent restenosis.
    Ortolani P; Marzocchi A; Gaiba W; Neri S; Marrozzini C; Palmerini T; Aquilina M; Branzi A
    Ital Heart J; 2003 Sep; 4(9):646-50. PubMed ID: 14635385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.